Oxidative stress and lipid retention in vascular grafts comparison between venous and arterial conduits

Circulation

Volumn 103, Issue 19, 2001, Pages 2408-2413

  Shi, Yi ^a   Patel, Sachin ^a   Davenpeck, Kelly L ^a   Niculescu, Rodica ^a   Rodriguez, Evelio ^b   Magno, Michael G ^a   Ormont, Michael L ^b   Mannion, John D ^b   Zalewski, Andrew ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Atherosclerosis; Bypass; Grafting; Remodeling

Indexed keywords

EPITOPE; GLYCOSAMINOGLYCAN; LOW DENSITY LIPOPROTEIN; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY GRAFT; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD VESSEL GRAFT; CAROTID ARTERY; CONTROLLED STUDY; ENZYME ACTIVITY; HEART MUSCLE REVASCULARIZATION; IMMUNOREACTIVITY; LIPID STORAGE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SAPHENOUS VEIN GRAFT; SWINE; TREATMENT OUTCOME;

EID: 0035873991     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.103.19.2408     Document Type: Article

References (35)

1. Motwani JG, Topol EJ. Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention. Circulation. 1998;97: 916-931.
2. Marin ML, Veith FJ, Panetta TF, et al. Saphenous vein biopsy: a predictor of vein graft failure. J Vasc Surg. 1993;18:407-415.
3. Angelini GD, Bryan AJ, Williams HMJ, et al. Distention promotes platelet and leukocyte adhesion and reduces short-term patency in pig arteriovenous bypass grafts. J Thorac Cardiovasc Surg. 1990;99: 433-439.
4. Yang Z, von Segesser L, Bauer E, et al. Different activation of the endothelial L-arginine and cyclooxygenase pathway in the human mammary artery and saphenous vein. Circ Res. 1991;68:52-60.
5. Yang Z, Oemar BS, Carrel T, et al. Different proliferative properties of smooth muscle cells of human arterial and venous bypass vessels. Circulation. 1998;97:181-187.
6. Holifield B, Helgason T, Jemelka S, et al. Differentiated vascular myocytes: are they involved in neointimal formation? J Clin Invest. 1996;97: 814-825.
7. Shi Y, O'Brien JE, Mannion JD, et al. Remodeling of autologous saphenous vein grafts: the role of perivascular myofibroblasts. Circulation. 1997;95:2684-2693.
8. Kunsch C, Medford RM. Oxidative stress as a regulator of gene expression in the vasculature. Circ Res. 1999;85:753-766.
9. Rao GN, Berk BC. Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression. Circ Res. 1992;70: 593-599.
10. Li PF, Dietz R, von Harsdorf R. Differential effects of hydrogen peroxide and superoxide anion on apoptosis and proliferation of vascular smooth muscle cells. Circulation. 1997;96:3602-3609.
11. Marui N, Offerman MK, Swerlick R, et al. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J Clin Invest. 1993;92:1866-1874.
12. Yla-Hertualla S, Rosenfeld ME, Parthasarathy S, et al. Gene expression in macrophage-rich human atherosclerotic lesions: 15-lipooxygenase and acetyl LDL receptor mRNA colocalize with oxidation-specific lipid-protein adducts. J Clin Invest. 1991;87:1146-1152.
13. Abrahamsson T, Brandt U, Marklund SL, et al. Vascular bound recombinant extracellular superoxide dismutase type C protects against detrimental effects of superoxide radicals on endothelium-dependent arterial relaxation. Circ Res. 1992;70:264-271.
14. Stralin P, Karlsson K, Johansson BO, et al. The interstitium of the human arterial wall contains very large amounts of extracellular superoxide dismutase. Arterioscler Thromb Vasc Biol. 1995;15:2032-2036.
15. Wang HD, Pagano PJ, Du Y, et al. Superoxide anion from the adventitia of the rat thoracic aorta inactivates nitric oxide. Circ Res. 1998;82: 810-818.
16. Pagano PJ, Clark JK, Cifuentes-Pagano ME, et al. Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: enhancement by angiotensin II. Proc Natl Acad Sci USA. 1997;94:14483-14488.
17. Weiner BH, Ockene IS, Jarmolych J, et al. Comparison of pathologic and angiographic findings in a porcine preparation of coronary atherosclerosis. Circulation. 1985;72:1081-1086.
18. Fukai T, Galis Z, Meng XP, et al. Vascular expression of extracellular superoxide dismutase in atherosclerosis. J Clin Invest. 1998;101: 2101-2111.
19. Assem M, Teyssier J-R, Benderitter M, et al. Pattern of superoxide dismutase enzymatic activity and RNA changes in rat heart ventricles after myocardial infarction. Am J Pathol. 1997;151:549-555.
20. Famdale RW, Buttle DJ, Barrett AJ. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochem Biophys Acta. 1986;883:173-177.
21. Shi Y, O'Brien JE Jr, Ala-Kokko L, et al. Origin of extracellular matrix synthesis during coronary repair. Circulation. 1997;95:997-1006.
22. Hishikawa K, Oemar BS, Yang Z, et al. Pulsatile stretch stimulates superoxide production and activates nuclear factor-κB in human coronary smooth muscle. Circ Res. 1997;81:797-803.
23. Brody WR, Angell WW, Kosek JC. Histologic fate of the venous coro. nary artery bypass in dogs. Am J Pathol. 1972;66:111-130.
24. Kockx MM, Cambier BA, Bonier HE, et al. The modulation of smooth muscle cell phenotype is an early event in human aorto-coronary saphenous vein grafts. Virchows Arch A Pathol Anal Histopathol. 1992; 420:155-162.
25. O'Brien JE, Ormont ML, Shi Y, et al. Early injury to the media after saphenous vein grafting. Ann Thorac Surg. 1998;65:1273-1278.
26. 2 production in the pig coronary artery. Circulation. 1997;96:3593-3601.
27. Pollman MJ, Hall JL, Gibbons GH. Determinants of vascular smooth muscle cell apoptosis after balloon angioplasty injury: influence of redox state and cell phenotype. Circ Res. 1999;84:113-121.
28. Huynh TT, Davies MG, Trovato MJ, et al. Reduction of lipid peroxidation with intraoperative superoxide dismutase treatment decreases intimal hyperplasia in experimental vein grafts. J Surg Res. 1999;84:223-232.
29. Patterson C, Ruef J, Madamanchi NR, et al. Stimulation of a vascular smooth muscle cell NAD(P)H oxidase by thrombin. J Biol Chem. 1999; 274:19814-19822.
30. Griendling KK, Sorescu D, Ushio-Fukai M, NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res. 2000;86:494-501.
31. Chester AH, Morrison KJ, Yacoub MH. Expression of vascular adhesion molecules in saphenous vein coronary bypass grafts. Ann Thorac Surg. 1998;65:1685-1689.
32. Hurt-Camejo E, Olson U, Wiklund O, et al. Cellular consequences of the association of apoB lipoproteins with proteoglycans: potential contribution to atherogenesis. Arterioscler Thromb Vasc Biol. 1997;17: 1011-1017.
33. Camejo G, Fager G, Rosengren B, et al. Binding of low density lipoproteins by proteoglycans synthesized by proliferating and quiescent human arterial smooth muscle cells. J Biol Chem. 1993;268:14131-14137.
34. Shi Y, Niculescu R, Williams KJ, et al. Myofibroblast involvement in glycosaminoglycan synthesis and lipid retention during coronary repair. J Vase Res. 2000;37:399-407.
35. The Post CABG Trial Investigators. The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary artery bypass grafts. N Engl J Med. 1997;336:153-162.